ARCHIVES

“5 A Day” Review Underway to Check Program’s Health at NCI.

This article is from The Cancer Letter archive.

Vol. 26 No. 13 | March 31, 2000

Download PDF Visit The Full Archive

Related Articles

Hammer, ACS Agree n Procedures for Award Of Facilities Survey Contract

March 30, 1984

FDA Approves Gleevec For First Line Rx Of CML

January 31, 2003

Community Assn. Meeting Includes Provocative Workshops

January 31, 1975

FDA Approves Cyramza for Stomach Cancer; Zykadia in NSCLC; Lipiodol for HCC Imaging; And Cobas HPV Test for Primary Screening

April 25, 2014

NIH Revises K Series Awards; RFP Available; Program Announcement

June 9, 1995

FDA Oncologic Drug Committee Agrees That “Kitty Fight” With NCI Should Be Negotiated

November 28, 1975